Berenberg analyst Victoria Lambert raised the firm’s price target on Fresenius Medical (FMS) to EUR 55 from EUR 47 and keeps a Buy rating on the shares.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical price target raised to $25 from $23 at Truist
- Fresenius Medical Care Rejoins DAX 40, Signifying Strategic Success
- Fresenius Medical Care Announces Release of Bond Guarantee
- Cara Therapeutics, Tvardi Therapeutics enter definitive merger agreement
- Fresenius Medical Care Resolves Legal Proceedings on Company Restructuring